To date, most evidence suggests that FAK overexpression and FAK phosphorylation are markers for invasive and metastatic tumors, including Gastric cancer, colon cancer, thyroid cancer, ovarian cancer, prostate cancer, oral cancer [40–45]. This evidence concerns the gene PTK2 and ovarian carcinoma.